C-Ray Therapeutics
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
C-Ray Therapeutics - overview
Established
2021
Location
Chengdu, Sichuan, China
Primary Industry
Biotechnology
About
Founded in 2021 and based in Chengdu, China, C-Ray Therapeutics operates as a pharmaceutical company that focuses on the development and production of radiopharmaceuticals. Tongrui Biopharmaceutical (Shanghai) Co. , Ltd is the branch office of the company. It also has another branch in Beijing.
The company has applied for 15 patents. It cooperated with Tongyi Pharmaceutical, Tongrun Bio, and other companies. In June 2023, the company's Zhangjiang R&D laboratory was put into use. In November 2024, C-Ray Therapeutics raised a series A+ funding for over USD 100 million.
C-Ray Therapeutics engages in the research, development, production, clinical application, and commercialization of radiopharmaceuticals. Its related products have been officially approved by the US FDA for clinical treatment. The company provides molecular imaging CRO and companion diagnostic development services, verification services for the drugability of new drugs developed for innovative targets, CRDMO services, etc. The company generates revenue by providing radiopharmaceuticals.
The company will use the series A+ funding for the improvement of targeted precursor discovery platforms, RDC's high-throughput drug screening capabilities upgrade, and research and development of drug and product pipelines.
Current Investors
HBM Partners, 6 Dimensions Capital, JR Capital
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Biopharmaceuticals, Healthcare IT, Oncology/Cancer Treatment, Specialty Pharmaceuticals, Pharmaceutical Research & Development
Website
www.c-raytherapeutics.com
Verticals
HealthTech
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.